Annual CFI:
$755.56M+$921.36M(+555.70%)Summary
- As of today, SRPT annual cash from investing is $755.56 million, with the most recent change of +$921.36 million (+555.70%) on December 31, 2024.
- During the last 3 years, SRPT annual cash from investing has risen by +$260.15 million (+52.51%).
- SRPT annual cash from investing is now at all-time high.
Performance
SRPT Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFI:
$232.40M+$200.19M(+621.49%)Summary
- As of today, SRPT quarterly cash from investing is $232.40 million, with the most recent change of +$200.19 million (+621.49%) on September 30, 2025.
- Over the past year, SRPT quarterly cash from investing has increased by +$361.23 million (+280.40%).
- SRPT quarterly cash from investing is now -69.59% below its all-time high of $764.12 million, reached on December 31, 2024.
Performance
SRPT Quarterly Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
$737.55M+$361.23M(+95.99%)Summary
- As of today, SRPT TTM cash from investing is $737.55 million, with the most recent change of +$361.23 million (+95.99%) on September 30, 2025.
- Over the past year, SRPT TTM cash from investing has increased by +$810.47 million (+1111.52%).
- SRPT TTM cash from investing is now -2.38% below its all-time high of $755.56 million, reached on December 31, 2024.
Performance
SRPT TTM Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
SRPT Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +555.7% | +280.4% | +1111.5% |
| 3Y3 Years | +52.5% | +1115.5% | +169.6% |
| 5Y5 Years | +163.5% | +329.8% | +3731.4% |
SRPT Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +172.2% | -69.6% | +179.8% | -2.4% | +169.6% |
| 5Y | 5-Year | at high | +172.2% | -69.6% | +129.6% | -2.4% | +169.6% |
| All-Time | All-Time | at high | +172.2% | -69.6% | +129.6% | -2.4% | +169.6% |
SRPT Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $232.40M(+621.5%) | $737.55M(+96.0%) |
| Jun 2025 | - | $32.21M(+111.1%) | $376.33M(+53.2%) |
| Mar 2025 | - | -$291.18M(-138.1%) | $245.59M(-67.5%) |
| Dec 2024 | $755.56M(+555.7%) | $764.12M(+693.1%) | $755.56M(+1136.2%) |
| Sep 2024 | - | -$128.82M(-30.7%) | -$72.92M(+52.9%) |
| Jun 2024 | - | -$98.53M(-145.0%) | -$154.66M(-481.9%) |
| Mar 2024 | - | $218.80M(+440.0%) | $40.50M(+124.4%) |
| Dec 2023 | -$165.80M(+84.2%) | -$64.36M(+69.4%) | -$165.80M(-80.9%) |
| Sep 2023 | - | -$210.57M(-317.9%) | -$91.65M(-166.4%) |
| Jun 2023 | - | $96.63M(+673.6%) | $138.04M(+155.5%) |
| Mar 2023 | - | $12.49M(+27.5%) | -$248.58M(+76.3%) |
| Dec 2022 | -$1.05B(-311.3%) | $9.80M(-48.8%) | -$1.05B(+1.2%) |
| Sep 2022 | - | $19.12M(+106.6%) | -$1.06B(-0.1%) |
| Jun 2022 | - | -$289.99M(+63.1%) | -$1.06B(-136.7%) |
| Mar 2022 | - | -$785.81M(>-9900.0%) | -$447.06M(-190.2%) |
| Dec 2021 | $495.41M(+507.0%) | -$2.58M(-112.7%) | $495.41M(+32.4%) |
| Sep 2021 | - | $20.27M(-93.7%) | $374.10M(-8.3%) |
| Jun 2021 | - | $321.06M(+104.9%) | $407.91M(+675.1%) |
| Mar 2021 | - | $156.67M(+226.5%) | $52.63M(+143.2%) |
| Dec 2020 | -$121.72M(-142.5%) | -$123.89M(-329.1%) | -$121.72M(-732.3%) |
| Sep 2020 | - | $54.08M(+258.0%) | $19.25M(+136.5%) |
| Jun 2020 | - | -$34.23M(-93.6%) | -$52.78M(-139.4%) |
| Mar 2020 | - | -$17.68M(-203.5%) | $133.81M(-53.3%) |
| Dec 2019 | $286.73M(+177.4%) | $17.08M(+195.1%) | $286.73M(+798.6%) |
| Sep 2019 | - | -$17.96M(-111.8%) | $31.91M(+335.8%) |
| Jun 2019 | - | $152.37M(+12.7%) | -$13.53M(+93.9%) |
| Mar 2019 | - | $135.23M(+156.9%) | -$221.00M(+40.3%) |
| Dec 2018 | -$370.49M(-107.2%) | -$237.74M(-275.0%) | -$370.49M(+40.9%) |
| Sep 2018 | - | -$63.40M(-15.1%) | -$626.45M(-43.0%) |
| Jun 2018 | - | -$55.09M(-286.3%) | -$438.10M(-8.7%) |
| Mar 2018 | - | -$14.26M(+97.1%) | -$403.06M(-125.4%) |
| Dec 2017 | -$178.81M(-98.3%) | -$493.69M(-495.1%) | -$178.81M(-254.0%) |
| Sep 2017 | - | $124.95M(+723.1%) | $116.11M(+8307.4%) |
| Jun 2017 | - | -$20.05M(-109.6%) | $1.38M(-98.6%) |
| Mar 2017 | - | $209.99M(+205.6%) | $100.37M(+211.3%) |
| Dec 2016 | -$90.19M(-1172.4%) | -$198.77M(-2044.2%) | -$90.19M(-332.7%) |
| Sep 2016 | - | $10.22M(-87.0%) | $38.76M(-34.9%) |
| Jun 2016 | - | $78.94M(+306.4%) | $59.56M(+472.3%) |
| Mar 2016 | - | $19.42M(+127.8%) | -$15.99M(-290.2%) |
| Dec 2015 | $8.41M(+105.3%) | -$69.82M(-325.1%) | $8.41M(-93.3%) |
| Sep 2015 | - | $31.02M(+816.9%) | $124.91M(+70.3%) |
| Jun 2015 | - | $3.38M(-92.3%) | $73.35M(+9.3%) |
| Mar 2015 | - | $43.83M(-6.1%) | $67.09M(+142.2%) |
| Dec 2014 | -$159.03M(-1262.5%) | $46.68M(+327.2%) | -$159.03M(+23.0%) |
| Sep 2014 | - | -$20.54M(-614.0%) | -$206.53M(-10.1%) |
| Jun 2014 | - | -$2.88M(+98.4%) | -$187.66M(-0.8%) |
| Mar 2014 | - | -$182.29M(>-9900.0%) | -$186.24M(-1495.6%) |
| Dec 2013 | -$11.67M(-919.4%) | -$822.00K(+51.0%) | -$11.67M(-3.5%) |
| Sep 2013 | - | -$1.68M(-15.4%) | -$11.27M(-16.5%) |
| Jun 2013 | - | -$1.45M(+81.2%) | -$9.68M(-12.5%) |
| Mar 2013 | - | -$7.72M(-1725.1%) | -$8.60M(-651.4%) |
| Dec 2012 | -$1.15M(+50.3%) | -$423.00K(-422.2%) | -$1.15M(+24.0%) |
| Sep 2012 | - | -$81.00K(+78.6%) | -$1.51M(+13.7%) |
| Jun 2012 | - | -$379.00K(-44.7%) | -$1.75M(+21.8%) |
| Mar 2012 | - | -$262.00K(+66.6%) | -$2.23M(+3.2%) |
| Dec 2011 | -$2.31M | -$784.00K(-145.0%) | -$2.31M(-13.7%) |
| Sep 2011 | - | -$320.00K(+63.0%) | -$2.03M(+7.7%) |
| Jun 2011 | - | -$865.00K(-157.4%) | -$2.20M(-22.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2011 | - | -$336.00K(+33.7%) | -$1.79M(+8.6%) |
| Dec 2010 | -$1.96M(-4.1%) | -$507.00K(-3.7%) | -$1.96M(+19.1%) |
| Sep 2010 | - | -$489.00K(-6.3%) | -$2.42M(-7.0%) |
| Jun 2010 | - | -$460.00K(+8.9%) | -$2.27M(-8.4%) |
| Mar 2010 | - | -$505.00K(+47.9%) | -$2.09M(-10.9%) |
| Dec 2009 | -$1.88M(-52.0%) | -$969.00K(-192.7%) | -$1.88M(-39.3%) |
| Sep 2009 | - | -$331.00K(-16.5%) | -$1.35M(-12.3%) |
| Jun 2009 | - | -$284.00K(+5.0%) | -$1.20M(-1.5%) |
| Mar 2009 | - | -$299.00K(+31.6%) | -$1.19M(+4.3%) |
| Dec 2008 | -$1.24M(-111.7%) | -$437.40K(-139.3%) | -$1.24M(-114.1%) |
| Sep 2008 | - | -$182.80K(+31.3%) | $8.79M(+7.4%) |
| Jun 2008 | - | -$266.20K(+24.5%) | $8.19M(-17.5%) |
| Mar 2008 | - | -$352.70K(-103.7%) | $9.92M(-6.2%) |
| Dec 2007 | $10.58M(+632.0%) | $9.59M(+1317.1%) | $10.58M(+1563.9%) |
| Sep 2007 | - | -$788.20K(-153.6%) | $635.60K(-20.0%) |
| Jun 2007 | - | $1.47M(+390.8%) | $794.10K(+162.3%) |
| Mar 2007 | - | $299.70K(+186.4%) | -$1.27M(+35.9%) |
| Dec 2006 | -$1.99M(+81.8%) | -$346.90K(+44.9%) | -$1.99M(+81.9%) |
| Sep 2006 | - | -$629.70K(-5.3%) | -$10.98M(-17.9%) |
| Jun 2006 | - | -$597.90K(-44.6%) | -$9.31M(+16.1%) |
| Mar 2006 | - | -$413.50K(+95.6%) | -$11.10M(-1.7%) |
| Dec 2005 | -$10.92M(-152.4%) | -$9.34M(-998.1%) | -$10.92M(-278.0%) |
| Sep 2005 | - | $1.04M(+143.5%) | $6.13M(-49.0%) |
| Jun 2005 | - | -$2.39M(-938.3%) | $12.04M(-49.2%) |
| Mar 2005 | - | -$230.00K(-103.0%) | $23.70M(+13.7%) |
| Dec 2004 | $20.84M(+234.8%) | $7.71M(+11.1%) | $20.84M(+112.8%) |
| Sep 2004 | - | $6.94M(-25.2%) | $9.79M(+168.9%) |
| Jun 2004 | - | $9.28M(+399.7%) | $3.64M(+116.8%) |
| Mar 2004 | - | -$3.10M(+7.1%) | -$21.66M(-40.1%) |
| Dec 2003 | -$15.46M(-544.2%) | -$3.33M(-520.7%) | -$15.46M(-40.2%) |
| Sep 2003 | - | $792.00K(+104.9%) | -$11.03M(-26.3%) |
| Jun 2003 | - | -$16.02M(-615.5%) | -$8.73M(-782.6%) |
| Mar 2003 | - | $3.11M(+183.1%) | -$989.00K(+58.8%) |
| Dec 2002 | -$2.40M(+81.2%) | $1.10M(-64.5%) | -$2.40M(+82.3%) |
| Sep 2002 | - | $3.09M(+137.3%) | -$13.58M(+22.8%) |
| Jun 2002 | - | -$8.28M(-587.7%) | -$17.60M(-76.7%) |
| Mar 2002 | - | $1.70M(+116.8%) | -$9.96M(+22.0%) |
| Dec 2001 | -$12.77M(-1065.3%) | -$10.08M(-989.3%) | -$12.77M(-315.0%) |
| Sep 2001 | - | -$925.70K(-43.7%) | -$3.08M(-22.8%) |
| Jun 2001 | - | -$644.40K(+42.1%) | -$2.51M(-18.7%) |
| Mar 2001 | - | -$1.11M(-183.5%) | -$2.11M(-92.7%) |
| Dec 2000 | -$1.10M(-119.1%) | -$392.90K(-10.6%) | -$1.10M(-36.9%) |
| Sep 2000 | - | -$355.30K(-42.3%) | -$800.50K(-50.7%) |
| Jun 2000 | - | -$249.70K(-155.3%) | -$531.20K(-41.2%) |
| Mar 2000 | - | -$97.80K(-0.1%) | -$376.10K(+23.3%) |
| Dec 1999 | -$500.00K(+80.8%) | -$97.70K(-13.6%) | -$490.40K(+16.3%) |
| Sep 1999 | - | -$86.00K(+9.1%) | -$585.60K(+76.7%) |
| Jun 1999 | - | -$94.60K(+55.4%) | -$2.52M(+5.7%) |
| Mar 1999 | - | -$212.10K(-10.0%) | -$2.67M(-3.6%) |
| Dec 1998 | -$2.60M(-420.0%) | -$192.90K(+90.4%) | -$2.58M(+4.0%) |
| Sep 1998 | - | -$2.02M(-718.3%) | -$2.68M(-303.3%) |
| Jun 1998 | - | -$246.70K(-107.3%) | -$665.70K(-7.5%) |
| Mar 1998 | - | -$119.00K(+60.3%) | -$619.00K(-23.8%) |
| Dec 1997 | -$500.00K(-600.0%) | -$300.00K(>-9900.0%) | -$500.00K(-150.0%) |
| Sep 1997 | - | $0.00(+100.0%) | -$200.00K(0.0%) |
| Jun 1997 | - | -$200.00K(>-9900.0%) | -$200.00K(>-9900.0%) |
| Mar 1997 | - | $0.00 | $0.00 |
| Dec 1996 | $100.00K | - | - |
FAQ
- What is Sarepta Therapeutics, Inc. annual cash from investing?
- What is the all-time high annual cash from investing for Sarepta Therapeutics, Inc.?
- What is Sarepta Therapeutics, Inc. annual cash from investing year-on-year change?
- What is Sarepta Therapeutics, Inc. quarterly cash from investing?
- What is the all-time high quarterly cash from investing for Sarepta Therapeutics, Inc.?
- What is Sarepta Therapeutics, Inc. quarterly cash from investing year-on-year change?
- What is Sarepta Therapeutics, Inc. TTM cash from investing?
- What is the all-time high TTM cash from investing for Sarepta Therapeutics, Inc.?
- What is Sarepta Therapeutics, Inc. TTM cash from investing year-on-year change?
What is Sarepta Therapeutics, Inc. annual cash from investing?
The current annual cash from investing of SRPT is $755.56M
What is the all-time high annual cash from investing for Sarepta Therapeutics, Inc.?
Sarepta Therapeutics, Inc. all-time high annual cash from investing is $755.56M
What is Sarepta Therapeutics, Inc. annual cash from investing year-on-year change?
Over the past year, SRPT annual cash from investing has changed by +$921.36M (+555.70%)
What is Sarepta Therapeutics, Inc. quarterly cash from investing?
The current quarterly cash from investing of SRPT is $232.40M
What is the all-time high quarterly cash from investing for Sarepta Therapeutics, Inc.?
Sarepta Therapeutics, Inc. all-time high quarterly cash from investing is $764.12M
What is Sarepta Therapeutics, Inc. quarterly cash from investing year-on-year change?
Over the past year, SRPT quarterly cash from investing has changed by +$361.23M (+280.40%)
What is Sarepta Therapeutics, Inc. TTM cash from investing?
The current TTM cash from investing of SRPT is $737.55M
What is the all-time high TTM cash from investing for Sarepta Therapeutics, Inc.?
Sarepta Therapeutics, Inc. all-time high TTM cash from investing is $755.56M
What is Sarepta Therapeutics, Inc. TTM cash from investing year-on-year change?
Over the past year, SRPT TTM cash from investing has changed by +$810.47M (+1111.52%)